Clinical trial
A Phase 2 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Ascending Dose Study of SB206 in Subjects With Molluscum Contagiosum
NCT03436615 is registered in ClinicalTrials.gov with Novan, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Ascending Dose Study of SB206 in Subjects With Molluscum Contagiosum
- Lead sponsor
- Novan, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 24, 2018
- Completion date
- November 3, 2018
- Enrollment
- 256 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.